As published by FDA on Import Alert 53-06
Guangdong Lilaiya Biotech Co.,Ltd.
On FDA Import Alert 53-06 (red list), published 2024-06-03
- Address
- Buildings 7 and 15, Area A, Vanyang Crowd Innovation Park, Guangde (Yingde) Industrial Park, Guangqing Special Economic Cooperation Zone, Yingde City, Qingyuan, Guangdong CHINA
- Country
- CHINA
- Date published
- 2024-06-03
- Product codes
- 53C--01, 53C--02, 53C--03, 53C--99
- Problems (FDA)
- 16035-FD&C RED #40 (ALLURA RED AC); 19140-FD&C YELLOW #5 (TARTRAZINE); 77489&77492-IRON OXIDES (SYNTHETIC FERROUS & FERRIC OXIDES); 77491 & 77499 - IRON OXIDES; TITANIUM DIOXIDE CFR-
Per FDA, as of 2026-10-31 · Import Alert 53-06 on FDA · All entries on this alert
What an import alert red list means
Firms on an import alert red list can have their listed products detained by FDA at the U.S. border without physical examination (DWPE) until FDA removes them. Being listed is not a court finding against the firm.
Found an error? Report it. We review every report within 48 hours.